Adaptive Approach to Naltrexone Treatment for Alcoholism

Naltrexone (NTX) is an opioid receptor antagonist used to prevent alcoholism relapse. This trial examines how to define “non-response” to treatment with NTX and what treatments are most effective for those who do or do not respond to the initial treatment.

Principal Investigator(s): David Oslin

Location: University of Pennsylvania

Funding: NIAAA Project R01AA017164

View all Case Studies HERE.

Case Studies

d3 Academy

Share This Page

Upcoming Events

View All Events
Presentation

Introduction to MAISYs

Prevention Science and Methodology Group Virtual Grand Rounds
January 24, 2023
Presentation

Introduction to MAISYs

University of Florida Health Outcomes and Biomedical Informatics Grand Rounds
February 13, 2023
Training Institute

Getting SMART

Comprehensive Program for Adaptive Interventions Training in Education (CATIE)
March 14, 2023
View All Events

LET’S STAY IN TOUCH

Join the d3center Mailing List

Keep up to date with the latest news, events, software releases, learning modules, and resources from the d3center.